I am quoting some remarks from the latest RiskHedge newsletter. Do we know what company will “revolutionize cancer treatment with own AI” ?
Fact #1: This tiny microcap has made a BIG breakthrough in the cancer drug market.Thanks to its proprietary AI, it successfully got its new prostate cancer drug into phase 2 trials 10 times faster and 50 times cheaper than the average drug takes. And it’s just getting started…
Fact #2: This microcap has four important milestones coming up…
Just one positive result could send its stock jumping 50% to 100% in a day.
Fact #3: My calculations tell me its three drugs in development could generate $10 billion in sales per year.
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.